Related Experiment Videos
Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study
1Clinical Psychologist and Course Tutor, South Wales Doctoral Course in Clinical Psychology, South Wales, UK.
General Hospital Psychiatry
|November 10, 2000
Summary
Mindfulness of movement training improved multiple sclerosis symptoms and balance in a pilot study. These benefits for multiple sclerosis patients were sustained at 3-month follow-up.
Area of Science:
- Neurology
- Mind-Body Medicine
Background:
- Multiple sclerosis (MS) is a chronic neurological disease impacting symptom management.
- Effective interventions for MS symptom relief are crucial for improving patient quality of life.
Purpose of the Study:
- To investigate the efficacy of a brief mindfulness of movement (MoM) intervention for symptom management in individuals with multiple sclerosis.
- To compare the outcomes of MoM training against a control group receiving standard care.
Main Methods:
- A pilot study involving eight participants with MS undergoing a six-session MoM course.
- Intervention included one-to-one instruction and audio-visual aids.
- Assessments included balance tests and a 22-symptom rating scale, with independent verification by a relative/friend, conducted pre-, post-intervention, and at 3-month follow-up.
Main Results:
- The MoM group reported significant improvements across a wide range of MS symptoms.
- These improvements were corroborated by independent ratings and maintained at 3-month follow-up.
- The MoM group demonstrated significant improvements in balance, which were also sustained.
- The control group showed no improvement and a tendency towards symptom deterioration.
Conclusions:
- Mindfulness of movement training shows promise as an effective intervention for improving symptom management and balance in people with multiple sclerosis.
- This pilot study suggests MoM may offer a valuable therapeutic approach for MS.
- Further research with larger sample sizes is recommended to confirm these findings and explore specific therapeutic components.